NCT03457337 2020-07-10S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLCHenan Cancer HospitalPhase 2 Unknown200 enrolled